Search research articles
Contact Us
Filters
Showing results (551-560 of 732) with videos related to
Page
of 74
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2020
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
Keith T Flaherty, Robert J Gray, Alice P Chen, et al.
Journal of the National Cancer Institute
|
November 7, 2019
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307
Julie R Gralow, William E Barlow, Alexander H G Paterson, et al.
Nature Medicine
|
February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents
Abraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Biorxiv : the Preprint Server for Biology
|
May 11, 2021
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19
Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Frontiers in Immunology
|
March 21, 2022
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Journal of the National Cancer Institute
|
June 19, 2013
Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials
Jeffrey S Abrams, Margaret M Mooney, James A Zwiebel, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Page
of 74
Search research articles
Search
Showing results (551-560 of 732) with videos related to
Sort By:
Page
of 74
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2020
Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
Keith T Flaherty, Robert J Gray, Alice P Chen, et al.
Journal of the National Cancer Institute
|
November 7, 2019
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307
Julie R Gralow, William E Barlow, Alexander H G Paterson, et al.
Nature Medicine
|
February 9, 2026
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents
Abraham Shaked, Alex Sagar, Kim M Olthoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2015
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S Herbst, David R Gandara, Fred R Hirsch, et al.
Biorxiv : the Preprint Server for Biology
|
May 11, 2021
Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19
Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Frontiers in Immunology
|
March 21, 2022
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
Sokratis A Apostolidis, Amrita Sarkar, Heather M Giannini, et al.
Journal of the National Cancer Institute
|
June 19, 2013
Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials
Jeffrey S Abrams, Margaret M Mooney, James A Zwiebel, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
Seth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Page
of 74